Cerner Acquires French Information Technology Company; Acquisition strengthens IT leader's commitment to European market.

KANSAS CITY, Mo. & PARIS -- Cerner Corp. (Nasdaq:CERN) announced today it has acquired Axya Systemes, a Paris-based healthcare information technology company that specializes in financial, administrative and clinical solutions for hospitals. The acquired company's new name is Cerner France. This transaction will expand Cerner's presence in France and will bring significant intellectual property and knowledge of the French healthcare market.

"Cerner and Axya have a shared mission to improve the quality and efficiency of healthcare around the world through information technology," said Trace Devanny, Cerner president. "Together we are better positioned to capitalize on the many opportunities available in all segments of the French healthcare market. Axya is an excellent fit within Cerner because of our common cultures, complementary solutions and similar views on the importance of unified architecture."

Prior to the acquisition, Axya was a privately held company with a diverse client base that includes academic, private and public hospitals in France, Switzerland and Morocco. Axya was managed by its founders, Anne-Veronique Dufresnoy and David Kalfon, who will be key members of the Cerner management team in France.

"The healthcare information technology landscape in France is changing. We believe that being a part of a global organization will be critical in addressing the significant opportunities developing in the market," said Dufresnoy. "We are now better positioned to accelerate our growth and respond to greater market demand. We are very excited to become an integral part of Cerner's global organization."

The acquisition is not expected to have a material impact on Cerner's 2005 financial results.

Cerner Corp. is taking the paper chart out of healthcare, eliminating error, variance and waste in the care process. With more than 1,500 clients worldwide, Cerner is the leading supplier of healthcare information technology. The following are trademarks of Cerner: Cerner, Cerner's logo, NASDAQ: CERN, www.cerner.com.

This release contains forward-looking statements that involve a number of risks and uncertainties. It is important to note that the Company's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "positioned", "will", and "believe", variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: quarterly operating results may vary, stock price may be volatile, changes in the healthcare industry, significant competition, the Company's proprietary technology may be subjected to infringement claims or may be infringed upon, government regulations, the possibility of product-related liabilities, possible errors or failures in the performance of the Company's software, risks associated with the Company's global operations, the recruitment and retention of key personnel, risks related to third party suppliers, the potential inconsistencies in sales forecasts compared to actual sales; and, failure to reach the intended synergies of the transaction. Additional discussion of these and other factors affecting the Company's business is contained in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.